{"id":478667,"date":"2020-04-09T11:42:01","date_gmt":"2020-04-09T11:42:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=478667"},"modified":"2020-04-09T11:42:01","modified_gmt":"2020-04-09T11:42:01","slug":"alopecia-areata-epidemiology-forecast-to-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/alopecia-areata-epidemiology-forecast-to-2030_478667.html","title":{"rendered":"Alopecia Areata Epidemiology Forecast to 2030"},"content":{"rendered":"
\"Alopecia<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s ‘Alopecia Areata – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Alopecia Areata epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<\/div>\n

DelveInsight’s ‘Alopecia Areata – Epidemiology Forecast to 2030<\/a>‘ report delivers an in-depth understanding of the disease, historical and forecasted Alopecia Areata epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n

\"\"<\/strong><\/p>\n

The key facts of the report:<\/strong>
1. Approximately 2.5 million people are suffering from Alopecia Areata in the United States.
2. Alopecia Areata affects approximately two per cent of the general population at some point during their lifetime.<\/p>\n

Key benefits of the report:<\/strong>
1. Alopecia Areata market report covers a descriptive overview and comprehensive insight of the Alopecia Areata epidemiology and Alopecia Areata market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Alopecia Areata market report provides insights on the current and emerging therapies.
3. Alopecia Areata market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Alopecia Areata market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Alopecia Areata market.<\/p>\n

Request for sample pages: <\/strong>https:\/\/www.delveinsight.com\/sample-request\/alopecia-areata-epidemiology-forecast<\/p>\n

Scope of the report:
<\/strong>1. The Alopecia Areata report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
2. The Alopecia Areata Epidemiology Report and Model provide an overview of the risk factors and global trends of Alopecia Areata in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
3. The report provides insight about the historical and forecasted patient pool of Alopecia Areata in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
4. The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
5. The report assesses the disease risk and burden and highlights the unmet needs of Alopecia Areata
6. The report provides the segmentation of the Alopecia Areata epidemiology<\/p>\n

Table of contents:
<\/strong>1. Key Insights
2. Executive Summary of Alopecia Areata
3. Alopecia Areata: Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9.  Appendix
10. DelveInsight Capabilities
11. Disclaimer<\/p>\n

About DelveInsight:
<\/strong>DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Kritika Rehani
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 9193216187
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Las Vegas
State:<\/strong> Nevada
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DelveInsight Business Research LLP DelveInsight’s ‘Alopecia Areata – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Alopecia Areata epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-478667","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/478667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=478667"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/478667\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=478667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=478667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=478667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}